VC Catalog · venture ecosystem research library
VC Catalog home Beta

VC firm

Adjuvant Capital

Kingmaker TierBased on the data VC Catalog holds.

Kingmaker Tier: 84 out of 100

  • Biotech & therapeutics
  • Medical devices & diagnostics
  • Other
  • Women's & family health
  • Social impact
  • Global
  • Impact fund
  • VC
  • B2B
Investor type
VC
Investing status
Activeas of 2026-09-17Source (opens in a new tab)
Headquarters
New York, NY, United States
Assets under management
$300MStated by firm, as of 2026-09-17Source (opens in a new tab)
Funds
2
Legal name
Adjuvant Capital Management, LLC
Claim, correct or request removal

Record updated 30 September 2026

About

Adjuvant is a new type of venture capital firm. We finance the most promising life science technologies for high-burden public health challenges. We see enormous opportunity in historically overlooked market segments, and we leverage our unique expertise to translate these opportunities into social and financial returns for our investors.

Investment approach

Thesis
Our mission is simple: use venture capital strategies to deploy capital in the most promising public health technologies and ensure they are made accessible to those who need them most.Source (opens in a new tab)
Eligibility
Adjuvant directs the majority of its investment activity to opportunities that have human efficacy signals from a phase II-or-later clinical trial or similar arm’s-length evaluations.
Traction requirement
Adjuvant directs the majority of its investment activity to opportunities that have human efficacy signals from a phase II-or-later clinical trial or similar arm’s-length evaluations. We look for compelling proof-of-concept data to support our investment decisions.
Investing status notes
We invest in innovative technologies to address high-burden and neglected infectious diseases, maternal and child health, nutrition, and reproductive and sexual health.

Funds

ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND, L.P.
Main fund
ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND DE, L.P.
Main fund

SEC registration

Registered adviser
ADJUVANT CAPITAL, LP
SEC file number
802-129182
Registration
Exempt reporting adviser
Regulatory AUM
$170Mas of 2026-03-27
Private funds reported
2
Principal office
NEW YORK, NY, United States

Locations

Office
Schlieren, Switzerland
Office
New York, NY, United States
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy